LUNA:VIE
H Lundbeck A/S Class A
€7,72
arrow_upward
+1,45%(+0,11) 1D
13 ພ.ຈ., 17 ໂມງ 36 ນາທີ 00 ວິນາທີ GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LUNA...
Open
€7,75
High
€7,80
Low
€7,55
Mkt. cap
58,13 ຕື້
Avg. vol.
143,00
Volume
17,00
52-wk high
€8,17
52-wk low
€4,22
No. of employees
5 ພັນ
Open
€7,75
High
€7,80
Low
€7,55
Mkt. cap
58,13 ຕື້
Avg. vol.
143,00
Volume
17,00
52-wk high
€8,17
52-wk low
€4,22
No. of employees
5 ພັນ
News stories
From web sources and news partners
TradingView
·
1 ມື້ກ່ອນ
H. Lundbeck Q3 2026 Earnings Call Is Live
Morningstar
·
1 ມື້ກ່ອນ
Strong Demand For Vyepti Drives Improved Near-Term Outlook For Lundbeck
GuruFocus
·
1 ມື້ກ່ອນ
H. Lundbeck AS (HLUBF) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong Vyepti Momentum
Investing.com
·
2 ມື້ກ່ອນ
Earnings call transcript: Lundbeck lifts 2026 outlook on strong Q3 growth
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5 ພັນ
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitelundbeck.com